OptimizeRx to Present at William Blair & Company’s 40th Annual Growth Stock Conference, June 9-11, 2020
ROCHESTER, Mich., May 29, 2020 (GLOBE NEWSWIRE) — OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for […]
ROCHESTER, Mich., May 29, 2020 (GLOBE NEWSWIRE) — OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for […]
Excellent Surgical Response Noted at the Higher, 100 mg/m2 Dose Novel Gene-Mediated Immunotherapy is Safe and Demonstrates an AcceptableRisk/Benefit When Administered […]
NEW YORK, May 29, 2020 (GLOBE NEWSWIRE) — iFresh, Inc. (“iFresh” or the “Company”) (Nasdaq: IFMK), a leading Asian American […]
BOSTON, May 29, 2020 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development […]
NEW YORK, May 29, 2020 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development […]
HAMILTON, Bermuda, May 29, 2020 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company focused on discovering, […]
TORONTO, May 29, 2020 (GLOBE NEWSWIRE) — RioCan Real Estate Investment Trust (“RioCan”) (TSX: REI.UN) today announced that it is […]
Undifferentiated Pleomorphic Sarcoma is the Major Sarcoma Subtype to be Enrolled inTRACON’s Pivotal ENVASARC Trial of Envafolimab as a Single Agent […]
The addition of ublituximab to ibrutinib significantly improved PFS, ORR, CR rate, and increased rates of uMRD compared with ibrutinib […]
SAN DIEGO, May 29, 2020 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation […]